Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration

NCT02396537 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Pain

Interventions

DRUG: Lidocaine
DRUG: Midazolam
DRUG: 0.9% Saline

Sponsor

University of Alabama at Birmingham